# Unspecified GI

This is a subcategory of Gastrointestinal Agents.

## Formulary

### Preferred

| Preferred                    | Generic Name | Quantity | Time (Days) |
| :--------------------------- | :----------- | :------: | :---------: |
| Amitiza BvG ST               |              |          |             |
| Bisacodyl                    |              |          |             |
| Casanthranol/Docusate Sodium |              |          |             |
| Dicyclomine                  |              |          |             |
| Diphenoxylate/Atropine       |              |          |             |
| Lactulose                    |              |          |             |
| Linzess ST 145, 290mcg       |              |          |             |
| Loperamide                   |              |          |             |
| Movantik ST                  |              |          |             |
| Polyethylene Glycol          |              |          |             |
| Psyllium Fiber               |              |          |             |
| Senna                        |              |          |             |
| Xifaxan ST                   |              |          |             |

### Non-Preferred

| Non-Preferred | Generic Name | Quantity | Time (Days) |
| :------------ | :----------- | :------: | :---------: |
| Aemcolo       |              |          |             |
| Gattex        |              |          |             |
| Ibsrela       |              |          |             |
| Linzess 72mcg |              |          |             |
| Lubiprostone  |              |          |             |
| Motegrity     |              |          |             |
| Mytesi        |              |          |             |
| Relistor      |              |          |             |
| Symproic      |              |          |             |
| Trulance      |              |          |             |
| Zorbitive     |              |          |             |

## Length of Authorizations

365 Days except 3 days for Aemcolo

**All Authorizations**

Must be prescribed in accordance with FDA approved labeling

## Additional Criteria

### Step Therapy

Step Therapy Approval Criteria

-   Must have had an inadequate clinical response to at least **14 days** with at least **two preferred** drugs

### Non-Preferred

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **14 days** with at least **three preferred** drugs, if indicated for diagnosis
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=67)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=24)
